S-8510 phosphate
S-8510 (phosphate) is an inverse Benzodiazepine (BDZ) receptor agonist, with Kis of 34.6 nM, 36.2 nM for –GABA and +GABA respectively.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 151466-23-8
- 分子式: C12H13N4O6P
- 分子量:340.23
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
Ki: 34.6 nM (-GABA), 36.2 nM (+GABA)[1].
S-8510 has a relatively high affinity to BDZ receptors. The ratio of Ki values for each ligand with and without GABA is defined as the GABA ratio, which is considered as a biochemical index for BDZ receptor ligands. The GABA ratio for S-8510 or CGS8216 is close to the value for flumazenil which is considered as an antagonist or a very weak agonist. S-8510 (10-7 M) enhances LTP and this enhancement is antagonized by BDZ receptor antagonist, flumazenil. Flumazenil itself does not atfect LTP or evokes responses prior to tetanic stimulation. S-8510 has no effect on the field evoked potential up to 10-5 M. However, S-8510 increases the amplitude of the population spike at a dose of 10-4 M, and this effect is completely antagonized by concomitant application of flumazenil (10-4 M) [1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 151466-23-8
-
分子量 340.23
-
分子式 C12H13N4O6P
-
SMILES
O=P(O)(O)O.C12=NC=C3C(NC(C4=NOC=C4)=N3)=C1COCC2
-
別名
SB-737552 phosphate
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
Mice, Rats[1]
Proconvulsant actions of S-8510 are examined in combiition with a subconvulsive dose of convulsant (PTZ or strychnine) or minimal electroconvulsive shock in ddY mice. Each convulsant is administrated, simultaneously with the inverse agonist, whereas minimal electroconvulsive shock is applied 5 min after intravenous injection of the inverse agonist. The proconvulsant test of S-8510 on PTZ (52, 62.5, 75 or 90 mg/kg s.c.) or strychnine (0.25 mg/kg, s.c.)-induced convulsion is made. ED50 values for producing clonic convulsion to death in 50% of ddY mice are calculated. Anxiogenic actions of each inverse agonist are examined in the punished water licking method in Wistar rats. Each inverse agonist is administered per OS 30 min before the test trial. Antiamnesic actions of inverse agonists are examined in the water maze paradigm. Wistar rats are given 4 trials every day for consecutive 4 days. On the 5 th day, each animal has the retention test for 60 s. Amnesia is produced by intraperitoneally injected scopolamine at a dose of 0.5 mg/kg. Scopolamine and each inverse agonist are given 15 min and 30 min before the retention trial, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)